UK Prime Minister David Cameron has announced a collaboration involving JDRF and three other leading medical research charities to fund world-class science.
The four charities are working with the British Council to investigate globally challenging conditions and diseases.
JDRF, the British Heart Foundation, the MS Society and Parkinson’s UK are major contributors to the £3.2 million new research programme at leading universities across Britain and Israel. Mr Cameron announced the programme today via Twitter.
Scientists from universities including Cambridge, Cardiff, Edinburgh, Manchester, Nottingham and Oxford will be using cutting-edge research to find cures for type 1 diabetes, heart disease, liver disease, multiple sclerosis and Parkinson’s.
These new projects are the latest addition to the British Council’s Britain Israel Research and Academic Exchange programme (BIRAX) – a £10 million initiative of the British Council investing in world-leading research jointly undertaken by scientists in Britain and Israel. A call for applications was launched by Mr Cameron last year.
Clare McVicker, Director of Research Advocacy at JDRF in the UK, said: “If medical science is to one day triumph over serious conditions such as type 1 diabetes, international collaboration between the best investigating researchers is utterly vital. JDRF is thrilled to partner with BIRAX to expand its Regenerative Medicine Initiative.”
The type 1 diabetes researchers selected to receive new programme funding will explore exciting aspects of regenerative medicine using stem cell therapies. Regenerative medicine research is an important focus for JDRF given its aim to re-establish insulin production and mediate the immune system’s attack on insulin producing beta cells. This could free people with type 1 diabetes from the daily regime of insulin via injections or a pump.
Madi Jacobson, CEO of JDRF Israel said: "JDRF Israel is excited to take part in the Birax initiative, and proud of the leading Israeli researchers involved. It is truly inspiring to be part of a team which holds investing and promoting innovative medical research in high priority. We trust this collaboration of brilliant scientific minds from Israel and UK will improve the lives of millions affected by type 1 diabetes around the world.”
Alan Gemmell, Director of the British Council in Israel said: “BIRAX combines the best of what Britain and Israel can offer the world; world-class scientists working together to improve the lives of millions of people. When the UK’s education and research sectors engage with Israel, the benefits go beyond our two countries and can be truly universal.”
At JDRF we use the money you raise to fund the best type 1 diabetes research in the world. Find out more about our research programme.
Learn more about the BIRAX research initiative.